| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681878 | Clinical Neurology and Neurosurgery | 2018 | 5 Pages |
Abstract
Surgical management for recurrent glioblastoma appears to be a safe procedure which results in longer OS in comparison to non-surgical management. GTR may be of particular benefit to patients with unmethylated MGMT promoter rGB.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Andrej Pala, Anne Lea Schmitz, Andreas Knoll, Max Schneider, Michal Hlavac, Ralph König, Christian Rainer Wirtz, Jan Coburger,